Apex Molecular Limited members' voluntary liquidation
Active Company no. 06596885 Incorporated May 2008 SK postcode area
Block 19 Alderley Park, Mereside, Alderley Edge, SK10 4TG
The most recent insolvency notice for Apex Molecular Limited is a Notices to creditors (MVL), published 20 October 2026 in The London Gazette. The office holders are Simon Farr; Tom Bowes, appointed 15 October 2026. Its last accounts filed at Companies House, to 31 May 2026, showed total assets of £778k and net assets of £602k. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Last filed balance sheet
As at 31 May 2026 · total exemption full accounts · unaudited · filed 4 months before the first insolvency notice
Insolvency notices (3)
-
Notices to creditors (MVL) 20 Oct 2026
The notice informs creditors of APEX MOLECULAR LIMITED that they must submit their claim details to the joint liquidators by 15 November 2026, with a possible distribution if claims are not proved.
-
Appointment of liquidators (MVL) 20 Oct 2026
APEX MOLECULAR LIMITED has appointed Simon Farr and Tom Bowes as liquidators in a members' liquidation effective 15 October 2026.
-
Resolution for winding up (MVL) 20 Oct 2026
The notice announces that APEX MOLECULAR LIMITED has resolved to voluntarily wind up the company and has appointed Simon Farr and Tom Bowes as joint liquidators.
What happens next
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Owed money by Apex Molecular Limited?
A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.
Related guidance
Frequently asked questions
Is Apex Molecular Limited in financial difficulty?
No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Apex Molecular Limited (company no. 06596885) is a Notices to creditors (MVL), published 20 October 2026 in The London Gazette.
What were Apex Molecular Limited's last filed accounts?
Apex Molecular Limited's last accounts filed at Companies House, to 31 May 2026, showed total assets of £778k, cash of £600k, net assets of £602k. For a distressed company the last filing often predates the insolvency by a year or more.
How many insolvency notices does Apex Molecular Limited have?
Apex Molecular Limited has 3 insolvency notices recorded in The London Gazette, the most recent being a Notices to creditors (MVL) on 20 October 2026.
What happens next?
Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.
Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.